Phase II study of the combination of RAD001 and Letrozole in patients with recurrent endometrial cancer.

Trial Profile

Phase II study of the combination of RAD001 and Letrozole in patients with recurrent endometrial cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Everolimus; Letrozole
  • Indications Endometrial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top